Posted On: 11/15/2012 7:15:53 PM
Post# of 2146
The company is not valued based on ART though. That's the funny part to me. Its trading now on generics only at a low PE of 10. Not even the other R&D products, or products pending approval and launch. Not even on the value of 10% of Novel itself
(0)
(0)Scroll down for more posts ▼
